Acutaas Chemicals Promotes Manager to General Manager and Unit Head for Ankleshwar Facility
Acutaas Chemicals Limited has announced a key leadership appointment within its operations division, promoting Mr. Anurag Shukla to the role of General Manager Operations and Unit Head for the Ankleshwar facility. This designation was made effective July 2, 2026.Mr. Anurag Shukla, who previously served as Assistant General Manager - Operations at Acutaas Chemicals, has been promoted and designated as a Senior Management Personnel (SMP). The new role entails overseeing all operations of the company's Ankleshwar manufacturing facility.
The promotion recognizes Mr. Shukla's long-standing commitment and expertise within the organization. He has been associated with Acutaas Chemicals since September 1, 2021, progressing through roles, including Senior Manager and Assistant General Manager - Operations.
A table summarizing his tenure and background details is provided below:
| Role Aspect | Detail |
|---|---|
| Current Designation | General Manager Operations & Unit Head - Ankleshwar (SMP) |
| Effective Date | July 2, 2026 |
| Tenure at Acutaas | Since September 1, 2021 |
| Educational Qualification | Master of Science (Organic Chemistry) |
Prior to joining Acutaas Chemicals, Mr. Shukla possessed over 21 years of experience in the pharmaceutical API and intermediates manufacturing sector. His extensive background covers plant operations, project management, production oversight, quality systems, and regulatory compliance. He holds significant expertise in capacity enhancement, cost optimization, and leading global agency audits for manufacturing facilities.
Mr. Shukla's previous leadership positions were held with several reputed organizations, including Alembic Pharmaceuticals Limited, Laboratories Limited, Dishman Pharmaceuticals & Chemicals Limited, Kalki Healthcare Private Limited, and Avitech Nutrition Private Limited.
ACUTAAS Stock Price Movement
Acutaas Chemicals Limited shares rallied on a positive trading session today, settling at ₹3691.8 after climbing 3.71%. The stock not only achieved its 52-week high during intraday trading but also traded within a tight range of ₹3579.7 to ₹3725 amid significant volume.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.